Radar · Industry landscape · Israel
Life Sciences Industry Landscape of Israel
1,143 Life Sciences companies in Israel, in one picture: who is hiring, who is raising money, who founded them, where they are based, what the news is about and where the research is going. Updated September 2026.
1,143companies tracked
$9.7Bdisclosed funding
44hiring right now
547events · 24 months
336,757news articles · 12 months
Who leads Life Sciences in Israel
Shows 1,143 Israeli life‑sciences firms, highlighting the top hiring companies, the best‑funded firms, and the 44 currently hiring and 329 that have disclosed recent funding rounds.
open roles
Hiring now
ranked by live open roles
- 01
Lumenis9last posted Apr 2026
- 02
Insightec3last posted Feb 2026
- 03
CardiaCare2last posted Jul 2026
- 04
Medinol2last posted Feb 2026
- 05
RedHill Biopharma2last posted Jun 2026
- 06
AranBiotech2last posted Feb 2026
- 07
Danyel Biotech2last posted Jul 2026
- 08
Microbot Medical2last posted Jul 2026
44 companies hiring · 0 posted in the last 30 days
disclosed funding
Most funded
disclosed totals, all rounds
- 01
- 02
Novocure$510MPost IPO · Nov 2020
- 03
Vayyar$296MSeries E · Jun 2022
- 04
Enlivex Pharmaceuticals$235.4MPost IPO · Nov 2025 - 05
MValve Technologies$215MSeries C · Oct 2015
- 06
UroGen Pharma$202MPost IPO · Jul 2023
- 07
ForSight Robotics$190MSeries B · Jun 2025
- 08
PolyPid$187.1MPost IPO · Jun 2025
329 companies with disclosed rounds · $9.7B total
revenue
Revenue leaders
official filings first, else latest snapshot
- 01
- 02
- 03
Protalix BioTherapeutics$33.8MFY2022 filing
- 04
Todos Medical$12.2Msnapshot Dec 2021
- 05
Evogene$8.5Msnapshot Dec 2024
- 06
Oramed$2MFY2022 filing
- 07
Gamida Cell$890kFY2023 filing - 08
HeraMED$403kFY2023 filing
14 companies with a revenue figure
headcount
Largest teams
ranked by tracked headcount
- 01
- 02
- 03
biotechnology general300tracked employees
- 04
- 05
- 06
Nanox180tracked employees
- 07
Tag Medical Products165tracked employees
- 08
100 companies with headcount data
share of events
Share of voice
share of all tracked sector news events, 24 months
- 01
InnoCan Pharma8.9%86 tracked events
- 02
- 03
- 04
- 05
NurExone4.0%38 tracked events
- 06Enlivex Pharmaceuticals3.5%34 tracked events
- 07
Brainsway3.2%31 tracked events
- 08
MediWound3.2%31 tracked events
962 tracked events across 110 companies
web reach
Most-used apps
the sites in this sector the web visits most
- 01
MyHeritagetop 10kmyheritage.com
- 02
Woojer- Born to Feeltop 500kwoojer.com
- 03
sebocalmtop 500ksebocalm.co.il
- 04
Shamirtop 1Mshamir.com
- 05
Walabottop 1Mwalabot.com
- 06
Liviatop 5Mmylivia.com
- 07
- 08
Fugene Geneticstop 5Mfugene.co.il
238 companies here run a site with a measured audience · 5 of them sit inside the web’s top million
articles
In the news
Prism news coverage, last 12 months
- 01
HAGAR37articles in the window
- 02
- 03
- 04
- 05
- 06
- 07
IceCure Medical25articles in the window
- 08
75 of these companies drew sector coverage in the window
Radar
See all 1,143 Life Sciences companies in Israel
Filter by funding, headcount, hiring and location, and export the list.
How the Life Sciences ecosystem in Israel grew, 2016–2025
Displays the number of companies founded each year from 2016 to 2025, with the highest count of 63 in 2016 and only one new firm in 2025.
Companies founded / year
new Life Sciences companies in Israel
20162025
peak 63 in 2016
Companies raising / year
with a disclosed round that year
20162025
peak 73 in 2020
Disclosed funding / year
sum of disclosed rounds (USD)
20162025
peak $1.6B in 2020
Where Life Sciences companies in Israel are based
Hub 01
Tel Aviv
159 Life Sciences companies
27% of the Life Sciences companies across these hubs
159companies
$972.2Mdisclosed funding
6hiring now
Hub 02
Jerusalem
105 Life Sciences companies
18% of the Life Sciences companies across these hubs
105companies
$815.4Mdisclosed funding
2hiring now
Hub 03
Rehovot
75 Life Sciences companies
13% of the Life Sciences companies across these hubs
75companies
$639.4Mdisclosed funding
5hiring now
Hub 04
Haifa
65 Life Sciences companies
11% of the Life Sciences companies across these hubs
65companies
$873.5Mdisclosed funding
Hub 05
Ness Ziona
59 Life Sciences companies
10% of the Life Sciences companies across these hubs
59companies
$499.8Mdisclosed funding
3hiring now
Hub 06
Herzliya
51 Life Sciences companies
9% of the Life Sciences companies across these hubs
51companies
$728.1Mdisclosed funding
3hiring now
Hub 07
Netanya
37 Life Sciences companies
6% of the Life Sciences companies across these hubs
37companies
$94.5Mdisclosed funding
5hiring now
Hub 08
Petah Tikva
36 Life Sciences companies
6% of the Life Sciences companies across these hubs
36companies
$410.9Mdisclosed funding
2hiring now
The Life Sciences market map of Israel: what these companies actually do
- Enterprise Tech739 companies · $9.1B raised · 32 hiring
- Medical Devices473 companies · $5.9B raised · 24 hiring
- Biopharmaceuticals198 companies · $2.5B raised · 7 hiring
- Healthtech189 companies · $1.6B raised · 9 hiring
- Enterprise Software154 companies · $1.4B raised · 3 hiring
- Consumer Digital135 companies · $825.7M raised · 7 hiring
- Deep Tech129 companies · $1.1B raised · 10 hiring
- Chronic Disease Management70 companies · $522.2M raised · 5 hiring
- IoT in Healthcare69 companies · $445.8M raised · 4 hiring
- SaaS54 companies · $532.2M raised · 4 hiring
- In Vitro Diagnostics51 companies · $543.3M raised · 4 hiring
- At Home Diagnostics47 companies · $225.2M raised · 1 hiring
Monetization
How Life Sciences companies make money
How many companies earn revenue each way. Plenty use more than one model, so the counts add up to more than the sector.
Physical Commerce654
E-Commerce - Product496
Subscription324
Fee-For-Service141
Commission on Transaction39
Advertising28
E-Commerce - Service5
Licensing2
Funding, M&A and the deals moving Life Sciences in Israel
Earnings 169Funding 120Leadership 82M&A 47IPO 33Announcement 21Regulatory 17Fda Approval 12Product 11Contracts 10
- M&AEnlivex’s most recent acquisitions of RAIN tokens were made via partial exercises of the Company’s option to acquire up to 272,121,212,121 RAIN tokens from the Rain Foundation.2026-04-28
- M&ABiomX has acquired a majority stake in DFSL, a LADAR-based detection systems manufacturer, from Mandragola in a tech M&A deal valued at $6 million.2026-04-22
- M&AMedtronic plc (NYSE: MDT ), a global leader in healthcare technology, today announced it has completed its acquisition of CathWorks, a privately held medical device company, which aims to transform how coronary artery disease (CAD) is diagnosed and treated.2026-04-20
- M&ASpanish frozen bakery business Monbake Group has struck a deal to acquire local foodservice supplier Triticum.2026-04-15
- FundingAggregate gross proceeds to the Company from both transactions were approximately $3.5 million. The transactions closed on April 8, 2026.2026-04-08
- FundingInnocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it has closed its previously announced offering of an additional debenture of the Company (the "Debenture") to its largest shareholder, Tamar Innovest Ltd. ("Tamar Innovest") for gross proceeds of US $200,000 (the "Offering").2026-04-06
- FundingIceCure Medical Ltd. (Nasdaq: ICCM) (...) announced that it has entered into securities purchase agreements with healthcare focused institutional investors for the purchase and sale of 8,000,000 ordinary shares at a purchase price of $0.50 per share in a registered direct offering. The gross proceeds from the offering are expected to be approximately $4.0 million, before deducting placement agent fees and other offering expenses.2026-03-26
- FundingOSSIO has closed an initial $40 million senior credit facility, with an additional $10 million available to support future growth, according to Horizon Technology Finance Corporation and Monroe Capital.2026-02-13
- FundingThe gross proceeds to the Company from the offering are expected to be approximately $4.75 million , before deducting placement agent commissions and other offering expenses.2026-02-05
- M&AHaynes Boone represented Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company pioneering oral drug delivery solutions, in its strategic transaction with Lifeward Ltd., a revenue-generating medical robotics company.2026-01-13
Mergers and acquisitions
Deals from the last 24 months where a Life Sciences company in Israel was the buyer or the one bought, newest first. “Undisclosed” means the price was never published — not that the deal was worth nothing.
| Acquirer | Target | Deal value | Status | Date |
|---|---|---|---|---|
| $898M | Announced | 2026-04-27 | ||
| DFSL | $6M | Announced | 2026-04-22 | |
| $585M | Completed | 2026-04-20 | ||
| Monbake Group | undisclosed | Announced | 2026-04-15 | |
| $6M | Announced | 2026-03-24 | ||
| $5.8M | Announced | 2026-02-05 |
Who is listing, hiring leaders, launching and winning work
Details specific events like IPO filings, leadership changes, product launches and contract wins for companies in the sector.
IPO pipeline
19 companies listed or filing · last 24 months
Regentis BiomaterialsIPO · NYSE American · RGNT · 5 reportsDec 2025
SciVac TherapeuticsFollow-on Offering · 4 reportsFeb 2025
MacrocureIPO · 1 reportFeb 2025
BioBlast PharmaIPO · NASDAQ · ORPN · 2 reportsFeb 2025
CollplantFollow-on Offering · Nasdaq · CLGN · 3 reportsFeb 2025
Galmed PharmaIPO · NASDAQ · GLMD · 2 reportsFeb 2025
Leadership moves
18 tracked people moves · last 12 months
Biolojic DesignRoger Waltzman · Appointment → Chief Medical OfficerJan 2026
Product launches
tracked launches · last 12 months
PainReformDeepSolar reporting engine (SaaS)Nov 2025
Contract wins
4 customer wins · last 24 months
Polyrizonwon arrow aviationFeb 2026
Diagnostearwon renovateJan 2026
Regulatory & litigation
22 regulatory events · 2 tracked suits · 24 months
- Plaza Centers, Elbit Imaging v officers in Plaza and Elbit, heirs of the late Moti Zisser, real estate transaction dispute · SettledMay 2025
- Protalix shareholders v protalix biotherapeuticssecurities law violations / breach of fiduciary dutySep 2024
Earnings pulse
companies reporting results · last 24 months
35 companies reporting180 company-quarters trackedbeat 29miss 15in line 3
Half of these companies grew revenue faster than +29.0%, half slower.
Who is building Life Sciences in Israel
Profiles 921 founders and CEOs across 675 firms, noting that Tel Aviv University produced 95 alumni and that former employers include Intel (7) and McKinsey (2).
Founders and chief executives12 of 921, from the best-funded companies on this page
Ex-Opko Biologics. BGU Negev, Israel PhD
Ex-CEO XTL Biopharmaceuticals. Hebrew University of Jerusalem Israel BA, New York Universitys Stern School of Business MBA
8400, IATI, ex-ISL. Technion Israel Institute of Technology BA 2004, MSc 2006, Weizmann Institute of Science PhD 2010
Ex-Ph.D. in Biomedical Engineering Tel-Aviv University
Founder Augmedics, ex-Volume Elements. University of Cambridge MSc 2008, University of Oxford PhD 2011
Founder Ossio, ex-IDF Institute for Military Physiology. Columbia University 2004, Technion - Israel Institute of Technology 2006
ex-Mediline, PharmaSwiss, Eli Lilly. Tel Aviv University BA 1998, INSEAD MBA 2001
Bluewind Medical, ex-Direct Flow Medical, ex-White Pine Medical, Bowling Green State University, 1978
ex- Co-Founder NeuroVir Therapeutics, enon Pharmaceuticals, Aspreva Pharmaceuticals. University of Gottingen 2014
Where the founders studied
alma mater on record for 219 of 921 founders
Tel Aviv University95
Technion Israel Institute Technology45
Technion - Israel Institute of Technology20
The Hebrew University of Jerusalem15
Ben-Gurion University of The Negev13
Bar-Ilan University10
INSEAD7
University of Haifa6
Where they worked before
a previous employer on record for 10 of 921 founders
Intel7
McKinsey2
Microsoft1
Founders flagged as repeat founders
of 653 founders with a profile on this page
9
carry a repeat-founder flag
- flagged as repeat founders9
- no repeat-founder flag644
Women and men among the founders
first names matched for 791 of 921 founders
14%
of matched founders are women
- women111
- men680
Inferred from first names, using 119 million people who state their own gender: a first name counts only where at least 20 of them share it and at least 90% of those share the same gender. The other 130 founders go in neither column.
Radar
Look up the people behind Life Sciences companies in Israel
Search founders, executives and operators by company, role and location.
Who funds Life Sciences in Israel
Records 779 funding rounds since 2016 from 637 investors, with an average round size of $3.4 million.
| Investor · most active investors since 2016 | Rounds | Led | Latest |
|---|---|---|---|
| Europa | 125 | 4 | May 2026 |
| EIC Fund | 70 | 1 | Jul 2024 |
| Orbimed | 24 | 9 | Dec 2025 |
| OurCrowd | 17 | 8 | Oct 2025 |
| Pontifax | 14 | 6 | Jun 2025 |
| The Trendlines Group | 13 | 5 | Nov 2021 |
| Israel Innovation Authority | 13 | 4 | Mar 2024 |
| Triventures | 12 | 5 | Oct 2022 |
| Pitango | 11 | 6 | Jul 2025 |
| aMoon | 10 | 6 | Jul 2025 |
Stage mix · rounds since 2016
Seed & Angel110
Series A–B220
Series C+ / PE87
Grants, debt & other362
The typical round is $3.4M — half were bigger, half smaller.
The biggest Life Sciences funding rounds in Israel
Highlights the ten largest disclosed rounds, the biggest being MValve Technologies’ $200 million Series C funding.
| Company | Round | Size | When | Backers |
|---|---|---|---|---|
| Series C | $200M | Oct 2015 | Boston Scientific | |
| Series G | $150M | Jun 2024 | Fidelity Investments, Nexus NeuroTech Ventures, Ally Bridge Group +6 more | |
| Series F | $150M | Mar 2020 | Koch Disruptive Technologies | |
| Series E | $150M | Dec 2017 | Elbit Imaging, York Capital Management, GE Healthcare +5 more | |
| Series B | $125M | Jun 2025 | Eclipse, Adani Group, Fred Moll +1 more | |
| Series D | $109M | Nov 2019 | Battery Ventures, Bessemer Venture Partners, Claltech +5 more | |
| Series E | $108M | Jun 2022 | Koch Disruptive Technologies, Battery Ventures, Bessemer Venture Partners +5 more | |
| Series D | $105M | Jul 2024 | Novo Holdings, Viking Global Investors, RA Capital Management +4 more | |
| Series D | $93M | Jan 2022 | Horizons Ventures, Shavit Capital, Social Capital +8 more | |
| Series D | $82.5M | Jun 2023 | CPMG, H.I.G. Capital, Revival Healthcare Capital +2 more |
Venture round sizes · 2023–2025
<$1M4
$1–10M25
$10–50M25
$50–250M9
>$250M0
63 venture rounds with a disclosed amount in the window.
Fresh cheques · last 6 months
Series B$47.8MMay 2026
Series C$21MMay 2026
Series B$12MMay 2026
Series A$3.6MMay 2026
Post IPO$779kApr 2026
Series A$6MMar 2026
Series A$6MMar 2026
What the news says about Life Sciences in Israel
Counts 336,757 news articles in the last year, with coverage focusing on international politics, security policies and human‑rights issues.
News volume
Life Sciences coverage across Israel · articles per quarter
2021Q22026Q1
peak 155,550 in 2023Q4 · 336,757 articles in the last 12 tracked months
Tone of coverage
share of articles by dominant sentiment (positive / neutral / negative)
202120232025
Positive-tone share moved 42% → 22%, negative 56% → 77% across 2021–2025.
What the coverage is about
The subjects that dominate Life Sciences news in Israel. The arrow shows whether each one is being written about more or less than a year ago.
- International political relations111,247▲+81%
- Security and defense policies65,920▲+150%
- Human rights advocacy reports43,002→-6%
- Naval and aerial combat operations37,494▲+58%
- International relations and diplomacy35,198▲+123%
- Military technology advancements30,552▲+217%
- Non-combatant casualties and collateral damage26,660→-5%
- Genocide and ethnic cleansing26,502▲+17%
- Political asylum and refugee policies26,458→-7%
- Cybersecurity and cyber warfare26,089▲+249%
Most-covered companies · last 12 months
- 37
- 34
- 33
- 30
- 29
- 28
- 25
- 24
- 21
- 20
75 Life Sciences companies here were named in the news over this period.
Prism
Watch Life Sciences coverage in Israel as it happens
Prism follows these subjects story by story — which companies are named, what is said about them and how the tone moves.
Momentum
The words getting louder — and quieter
Which terms are showing up in more stories than a year ago, and which are fading. The percentage is the change in how many articles mention them.
diplomatic strategies+113%national security strategy+309%foreign policy analysis+130%multilateral diplomacy+156%geopolitical alliances+88%diplomatic engagements+171%nuclear proliferation+439%oil price volatility+109%humanitarian corridors+45%diplomatic protocol+141%
ceasefire violations-49%hostage negotiations-61%school bombings-37%campus police-80%campus safety-78%
The pressures the press keeps returning to
Three recurring angles in Israel Life Sciences coverage, and whether each is getting more attention year on year (through 2025).
Regulatory Risk ▲ rising
380,248 articles touch this dimension · 80.9% critical tone
20212025
signals: aerial bombardments, accidental bombings, diplomatic strategies
Funding Momentum ▲ rising
43,135 articles touch this dimension · 67.0% critical tone
20212025
signals: higher education funding, school funding battles, currency intervention policies
Growth ▲ rising
40,848 articles touch this dimension · 44.8% critical tone
20212025
signals: earnings report, oil price volatility, quarterly financials
What Life Sciences research is working on
Indexes 53,147 academic papers, of which 4,958 identify common problems, 1,880 issue cautions, and 23,660 discuss opportunities.
How this field talks about itself
Life Sciences papers (gold) against all published research (grey)
Descriptive40.2% · 17.3%2.3×
Promising30.4% · 37.4%0.8×
Breakthrough14.1% · 26.2%0.5×
Problem-identifying8.3% · 9.7%0.9×
Cautionary3.5% · 4.5%0.8×
Comparative2.4% · 3.9%0.6×
Life Sciences literature runs 2.3× more “descriptive” than science at large (40.2% vs 17.3% baseline).
How the work is done
Empirical48.8%
Reviews37.2%
Methods-led11.2%
Position pieces2.2%
Theoretical0.6%
How the research reads
80% positive · 16% neutral · 4% negative, across 53,147 papers.
The institutions behind the field
- 87k
- 75k
- 61k
- 49k
- 43k
- 38k
ranked by how often their work is cited
Researchers who shaped it
Ahmad Almilaji · Reiki Nishimura · Tomofumi Osako · Yasuyuki Nishiyama · Rumiko Tashima · Masahiro Nakano · Glenn R. Gibson · Gregor Reid
The most-cited breakthroughs
- Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity · 9k cites
- In situ click chemistry generation of cyclooxygenase-2 inhibitors · 8k cites
- U1 snRNP regulates cancer cell migration and invasion in vitro · 7k cites
- Comprehensive molecular profiling of lung adenocarcinoma · 6k cites
- Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signal · 6k cites
Common problems researchers identify4,503 papers · 7 recurring themes
Problems · theme 01
Sustainable Biofuel and Biorefinery Challenges
781 papers · 17.3% of this block
▲ +11% share2022→2025 share of research on this subject
Researchers highlight ecological and technical hurdles in using microbes and plant biomass for renewable fuels and bioproducts.
Biofuel · Synthetic biology · Biomass · Biorefinery
“A review on the plant microbiome: Ecology, functions, and emerging trends in microbial application”
781 of these papers raise it as a problem
Problems · theme 02
Food Safety and Processing Risks
757 papers · 16.8% of this block
▲ +41% share2022→2025 share of research on this subject
Papers discuss microbial hazards, nutritional impacts, and safety concerns across the food production chain.
Food safety · Food processing · Food products · Human health
“Microbial Risks in Food: Evaluation of Implementation of Food Safety Measures”
757 of these papers raise it as a problem
Problems · theme 03
Gene Expression and mRNA Therapeutics Issues
711 papers · 15.8% of this block
▼ -32% share2022→2025 share of research on this subject
Studies examine obstacles in controlling gene expression, mRNA stability, and cell‑culture models for biomedical applications.
Messenger RNA · Gene · Cell culture · Gene expression
“Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research”
711 of these papers raise it as a problem
Problems · theme 04
Crop Nutrition and Food Security Gaps
693 papers · 15.4% of this block
▲ +24% share2022→2025 share of research on this subject
Research points to inefficiencies in fertiliser use, germplasm resources, and breeding strategies for resilient crops.
Agriculture · Crop · Food security · Germplasm
“Revisiting fertilisers and fertilisation strategies for improved nutrient uptake by plants”
693 of these papers raise it as a problem
Problems · theme 05
Plant Disease Management Limitations
691 papers · 15.3% of this block
▲ +34% share2022→2025 share of research on this subject
Works identify gaps in integrated pest management, host resistance, and pathogen‑vector dynamics.
Fungicide · Integrated pest management · Host · Disease management
“Innate Immunity in Plants: An Arms Race Between Pattern Recognition Receptors in Plants and Effectors in Microbial Pathogens”
691 of these papers raise it as a problem
Problems · theme 06
Antimicrobial Resistance Across Sectors
447 papers · 9.9% of this block
▲ +9% share2022→2025 share of research on this subject
Literature flags rising resistance in humans, livestock, and the environment and the need for stewardship.
Antibiotic resistance · Antimicrobial · Antibiotics · Drug resistance
“Antimicrobial resistance in humans, livestock and the wider environment”
447 of these papers raise it as a problem
Problems · theme 07
Fundamental Biological and Chemical Gaps
423 papers · 9.4% of this block
▼ -32% share2022→2025 share of research on this subject
Papers reveal basic uncertainties in metabolic pathways, enzyme functions, and molecular mechanisms.
Order · NAD+ kinase · Human being · Sodium
“Modalidade, polaridade e legibilidade em resumos académicos: uma análise comparativa multidisciplinar”
423 of these papers raise it as a problem
Cautions1,765 papers · 7 recurring themes
Cautions · theme 01
Cellular Toxicity and Oxidative Stress Concerns
379 papers · 21.5% of this block
▼ -21% share2022→2025 share of research on this subject
Authors caution about in‑vitro and in‑vivo models showing stress responses to nanomaterials and chemicals.
In vivo · Flow cytometry · In vitro · Oxidative stress
“Effects of Microplastics on Cell Viability, Phagocytic Activity and Oxidative Stress in Human Peripheral Blood Mononuclear Cells”
379 of these papers raise it as a problem
Cautions · theme 02
Genomic Selection and Trait Prediction Risks
257 papers · 14.6% of this block
▲ +26% share2022→2025 share of research on this subject
Studies warn of uncertainties when applying genomic selection to breeding and sustainable animal feed development.
Agriculture · Selection · Production · Trait
“Genomic selection in plant breeding: from theory to practice”
257 of these papers raise it as a problem
Cautions · theme 03
Feed Additive Safety and Efficacy
245 papers · 13.9% of this block
▼ -18% share2022→2025 share of research on this subject
Research emphasizes the need for rigorous evaluation of bioactive feed compounds and their health impacts.
Feed additive · Animal feed · Feed conversion ratio · Health benefits
“Natural Bioactive Compounds as Feed Additives: Strategies for Sustainable and Functional Livestock Production”
245 of these papers raise it as a problem
Cautions · theme 04
Food Contaminant Regulatory Uncertainty
240 papers · 13.6% of this block
▲ +16% share2022→2025 share of research on this subject
Papers discuss gaps in safety data and regulatory frameworks for emerging food additives and contaminants.
Food safety · Hygiene · Contamination · Food contaminant
“Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters”
240 of these papers raise it as a problem
Cautions · theme 05
DNA Damage and Repair Mechanism Limits
239 papers · 13.5% of this block
▼ -33% share2022→2025 share of research on this subject
Works highlight incomplete understanding of gene‑level damage responses and implications for disease diagnostics.
Gene · DNA damage · DNA repair · Gene expression
“Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations”
239 of these papers raise it as a problem
Cautions · theme 06
Co‑Selection of Antimicrobial Resistance
206 papers · 11.7% of this block
▲ +9% share2022→2025 share of research on this subject
Authors note the complex interplay of antibiotics, biocides, and metals driving resistance in pathogens.
Antibiotic resistance · Antibiotics · Antimicrobial · Bacteria
“Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses”
206 of these papers raise it as a problem
Cautions · theme 07
Pesticide Resistance Management Challenges
199 papers · 11.3% of this block
▲ +13% share2022→2025 share of research on this subject
Literature points to difficulties in dosing strategies and biological control integration to curb resistance.
Pesticide · Integrated pest management · PEST analysis · Biological pest control
“The use of fungal entomopathogens as endophytes in biological control: a review”
199 of these papers raise it as a problem
Opportunities22,038 papers · 7 recurring themes
Opportunities · theme 01
Advanced Antibody and Imaging Techniques
1,044 papers · 17.4% of this block
▼ -19% share2022→2025 share of research on this subject
Research explores novel antibodies, fluorescence methods, and flow cytometry for in‑vivo diagnostics and therapy.
Antibody · In vivo · Fluorescence · Flow cytometry
“Figure 4 from Ancestrally Diverse Autologous Patient-Derived Organoid–Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcom”
Opportunities · theme 02
Gene Modulation for Disease Intervention
1,032 papers · 17.2% of this block
▼ -28% share2022→2025 share of research on this subject
Papers present promising approaches using knockdown, up‑regulation, and apoptosis control to treat cancers and metabolic disorders.
Downregulation and upregulation · Apoptosis · Gene knockdown · Cell growth
“Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing <sc”
Opportunities · theme 03
Functional Plant‑Based Foods for Health
878 papers · 14.6% of this block
▲ +69% share2022→2025 share of research on this subject
Studies highlight bioactive ingredients, antioxidants, and sustainable protein sources to improve nutrition and aging.
Health benefits · Functional food · Ingredient · Antioxidant
“Plant-based functional foods for healthy aging: current trends, bioactive compounds, and future perspectives”
Opportunities · theme 04
Epigenetic and RNA‑Based Therapeutic Advances
823 papers · 13.7% of this block
▼ -33% share2022→2025 share of research on this subject
Research focuses on DNA methylation patterns, mRNA engineering, and detection platforms for precision medicine.
Gene · DNA methylation · Messenger RNA · DNA damage
“Convergent DNA methylation abnormalities at enhancers and bivalent promoters in human growth disorders”
Opportunities · theme 05
Novel Antimicrobials and Postbiotic Solutions
809 papers · 13.5% of this block
▲ +24% share2022→2025 share of research on this subject
Works investigate plant‑derived antimicrobials, resistance‑modifying agents, and microbial metabolites for animal health.
Antimicrobial · Antibiotic resistance · Biological pest control · Bacteria
“Plants as sources of new antimicrobials and resistance-modifying agents”
Opportunities · theme 06
Genetic Improvement of Crop Yield Traits
717 papers · 11.9% of this block
▼ -23% share2022→2025 share of research on this subject
Papers detail quantitative trait loci, germplasm analysis, and selection methods to boost agricultural productivity.
Germplasm · Trait · Quantitative trait locus · Selection
“Evaluation of Genetic Variability and Trait Interrelationships Using Advanced Wheat Lines to Increase Yield”
Opportunities · theme 07
Sustainable Biomass Conversion and Bioeconomy
697 papers · 11.6% of this block
▲ +31% share2022→2025 share of research on this subject
Research showcases microbial fermentation and by‑product valorisation to create renewable chemicals and fuels.
Biomass · Sustainability · Agriculture · Biofuel
“Microbial Fermentation: A Sustainable Strategy for Producing High-Value Bioactive Compounds for Agriculture, Animal Feed, and Human Health”
Which of these themes are growing fastest
Tracks how the share of world research on various themes has changed between 2022 and 2025.
Problems
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Food Safety and Processing Risks▲+41%
Plant Disease Management Limitations▲+34%
Crop Nutrition and Food Security Gaps▲+24%
Sustainable Biofuel and Biorefinery Challenges▲+11%
Antimicrobial Resistance Across Sectors▲+9%
Fundamental Biological and Chemical Gaps▼-32%
Gene Expression and mRNA Therapeutics Issues▼-32%
Cautions
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Genomic Selection and Trait Prediction Risks▲+26%
Food Contaminant Regulatory Uncertainty▲+16%
Pesticide Resistance Management Challenges▲+13%
Co‑Selection of Antimicrobial Resistance▲+9%
Feed Additive Safety and Efficacy▼-18%
Cellular Toxicity and Oxidative Stress Concerns▼-21%
DNA Damage and Repair Mechanism Limits▼-33%
Opportunities
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Functional Plant‑Based Foods for Health▲+69%
Sustainable Biomass Conversion and Bioeconomy▲+31%
Novel Antimicrobials and Postbiotic Solutions▲+24%
Advanced Antibody and Imaging Techniques▼-19%
Genetic Improvement of Crop Yield Traits▼-23%
Gene Modulation for Disease Intervention▼-28%
Epigenetic and RNA‑Based Therapeutic Advances▼-33%
Who files Life Sciences patents in Israel
Lists 12,904 patent filings from 2016‑2025 by 5,945 organisations, with top filers including YEDA RES & DEV, UNIV Ramot and the Technion RES & DEV Foundation.
12,904 filings 2016–20255,945 assigneespeak 1,544 in 2022
Filing momentum
patents published / year
20162025
Who files the most
- YEDA RES & DEV2,999
- UNIV Ramot1,505
- Technion RES & DEV Foundation1,018
- Evogene1,004
- Yissum RES DEV808
- Yissum RES DEV OF Hebrew UNIV Jerusa611
- Compugen559
- Hadasit MED RES Service545
Prism
Go deeper on Life Sciences research and innovation
Research themes, patent activity and the companies commercialising them, in one place.
Keep going
Track Life Sciences in Israel beyond this page
Radar finds and filters the companies. Prism watches what is being said about them.
About this data: built from Fliar's company, founder, funding, hiring, jobs, news, research and patent trackers, covering Israel. Counts are of companies we track, not of every company that exists. Updated September 2026.
Contact details
Reach this founder through Fliar Radar
Direct contact details for the people on this page are held in Fliar Radar, behind its own access controls.